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Purpose: To evaluate the use of noninvasive quantified contrast-enhanced power Doppler ultrasonography as a surrogate in the 
estimation of tumor hypoxia measured by invasive pO2 histography in canine tumors.
Material and Methods: Data of pretreatment tumor oxygenation status, tumor vascularity and blood volume, and tumor re-
sponse after radiation therapy was collected in 48 spontaneous malignant oral tumors (Table 1). Tumor oxygenation status was 
correlated to vascularity and blood volume, and influences on outcome after treatment were analyzed.
Results: Although vascularity and blood volume correlated moderately with median pO2 (r = 0.51 and 0.61; p = 0.001 and 
< 0.0001) and percentage of pO2 readings ≤ 2.5, 5, and 10 mmHg (r = –0.37 to –0.42; p < 0.01–0.03) for all tumors, they did not 
correlate within the different histology groups (p = 0.06–0.9). For all tumors, pretreatment oxygenation status, vascularity and 
blood volume were not found to be of prognostic value (Tables 2 and 3). 
Conclusion: These analyses show that quantified contrast-enhanced power Doppler ultrasonography does not represent a non-
invasive indirect method to assess tumor hypoxia measured by invasive pO2 histography. Both technologies were nonprognostic 
indicators in spontaneous malignant canine oral tumors.
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Korrelation des polarographisch gemessenen Sauerstoffdrucks mit quantifiziertem, kontrastverstärktem 
Power-Doppler-Ultraschall bei spontanen kaninen Tumoren und deren Einfluss auf das Tumorverhalten nach 
Strahlentherapie
Ziel: Untersuchung des nichtinvasiven quantifizierten, kontrastverstärkten Power-Doppler-Ultraschalls als alternative Methode 
bei der Einschätzung der Tumorhypoxie, die in spontanen Tumoren beim Hund mittels invasiver pO2-Histographie gemessen 
wurde.
Material und Methodik: Oxygenierungsstatus, Gefäßdichte und Blutvolumen vor der Behandlung sowie das Tumorverhalten 
nach Strahlentherapie wurden bei 48 Hunden mit spontanen malignen Tumoren der Maulhöhle untersucht (Tabelle 1). Der Oxygenie-
rungsstatus wurde zur Gefäßdichte und zum Blutvolumen korreliert, und Faktoren, die die Tumorantwort nach Strahlentherapie 
beeinflussen können, wurden analysiert.
Ergebnisse: Obwohl die Gefäßdichte sowie das Blutvolumen moderat mit dem Zentralwert (medianer pO2 [r = 0,51 und 0,61; 
p = 0,001 und < 0,0001]) und der prozentualen Verteilung der pO2-Messwerte ≤ 2,5, 5 und 10 mmHg (r = –0,37 bis –0,42; 
p < 0,01–0,03) für alle Tumoren korrelierte, verlor sich diese Korrelation innerhalb der einzelnen histologischen Gruppen 
(p = 0,06–0,9). Über alle Tumortypen gesehen, waren Oxygenierungsstatus, Gefäßdichte und Blutvolumen, gemessen vor der 
Strahlentherapie, nicht von prognostischem Wert (Tabellen 2 und 3). 
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Introduction
Tumor hypoxia, measured by invasive oxygen electrodes, 
has been found prognostic for tumor control and treatment 
outcome in a variety of human tumors [43]. Similarly, color 
and power Doppler studies have been performed in human 
tumors to determine the prognostic value of vascularity and 
perfusion. Significant associations between high vascular-
ity and tumor aggressiveness, metastatic rate and decreased 
patient survival have been shown for a variety of tumors [24, 
25, 32]. Vascularization and tissue hypoxia are known to be 
closely related and different noninvasive imaging methods 
have been evaluated to estimate tumor hypoxia relative to the 
invasive gold standard method of oxygen pressures measured 
polarographically. As a result, an estimation of average tissue 
oxygenation was described to be possible in spite of individual 
methodological limitations [13, 16, 39, 44].
For this study, the dog was chosen as a large animal tumor 
model in order to measure oxygen pressures polarographically 
and perform contrast-enhanced power Doppler ultrasonogra-
phy prior to radiation therapy (RT).
While often providing partially overlapping data, comple-
mentary techniques can be used to validate each other [28]. 
Therefore, the purpose of the present study was to investigate 
if pretreatment oxygenation levels measured via invasive po-
larographic measurements, and vascularity and blood vol-
ume as assessed by noninvasive quantified contrast-enhanced 
power Doppler ultrasonography correlated in different spon-
taneous canine oral tumors undergoing ionizing radiation. Fur-
thermore, the influence of pretreatment oxygenation levels, 
vascularity and perfusion on treatment outcome was evaluated 
in these patients.
Material and Methods
Animals
Dogs with spontaneously originating tumors of the oral cavity 
scheduled for treatment with RT at the Section of Radiation 
Oncology of the Vetsuisse Faculty, University of Zurich, Swit-
zerland, were included in the study. All dogs underwent diag-
nostic work-up as indicated for staging of the disease. Owner 
consent was obtained for the study which was approved by the 
Animal Ethics Council of the Canton of Zurich.
Anesthesia
All measurements and sampling procedures as well as subse-
quent RT were performed under general monitored anesthe-
sia as described [2]. For the study, contrast-enhanced power 
Doppler ultrasound was performed first, followed by the pO2 
measurements. Finally, dogs underwent RT.
Contrast-Enhanced Power Doppler Ultrasound of Tumors
Imaging was performed by use of a 5- to 12-MHz linear trans-
ducer (ATL 5000, Philips AG, Zurich, Switzerland). For 
contrast-enhanced power Doppler ultrasonography, settings 
as described in Ohlerth et al. [33] were used. A region of in-
terest (ROI) was drawn around the tumor boundaries and 
two measurements were computed for each ROI. Fractional 
area (FA) is calculated as the number of colored pixels in the 
ROI divided by the total number of pixels in the ROI multi-
plied by 100; it represents a vascularity index and calculates 
the percentage area of the tumor occupied by blood vessels. 
Color-weighted fractional area (CWFA) is used to assess per-
fusion and determines the mean blood volume within the tis-
sue. FA and CWFA were determined by calculating the me-
dian for five images.
pO2 Measurements and Tumor Volumes
Polarographic tumor oxygen partial pressure measurements 
were performed as previously described with an Eppendorf 
or Phönix pO2 Histograph (Helzel Medical System, Kalten-
kirchen, Germany) [1, 2, 14]. The needle was introduced 
into the tumor under ultrasound guidance in the same image 
plane in which the ultrasonographic examination was per-
formed [1, 3]. Three different electrode tracks and a mini-
mum of 50 recorded values were acquired for reliable sta-
tistical analysis [1, 3, 20]. To assess the biological relevance 
of tissue oxygenation status, the relative frequency of pO2 
values ≤ 2.5, 5, and 10 mmHg, as well as the median pO2 
were calculated. Tumor volume was calculated based on a 
combination of caliper and ultrasonographic measurements 
using the rotation ellipsoid formula (π/6 × height × width 
× depth) [40].
Radiation Therapy
RT was delivered with a 6-MV linear accelerator (Dynaray 
LA20, ABB/VARIAN, Zug, Switzerland) using 6-MV pho-
tons or 9- to 16-MeV electrons, as appropriate. Individualized 
treatment plans were generated using a three-dimensional 
treatment-planning system (Varian CadPlan® 6.0.8, Varian 
Medical Systems, Inc., Palo Alto, CA, USA) for photon plans, 
electron fields were calculated manually. Treatment plans 
were individually optimized to obtain optimal tumor cover-
age (100% ± 7.5%). Treatment protocols were assigned either 
with curative intent (15 × 3.5 Gy [for sarcomas], 17 × 3 Gy [for 
Schlussfolgerung: Diese Untersuchung zeigt, dass der kontrastverstärkte Power-Doppler-Ultraschall die invasive pO2-Histo-
graphie nicht ersetzt und beide Methoden keine prognostischen Indikatoren bei spontanen Tumoren der Maulhöhle des Hundes 
darstellen.
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squamous cell carcinomas], over 3.5 weeks) or in a coarse frac-
tionated scheme (5 × 6 Gy [sarcomas and malignant melano-
mas], over 10–14 days). Response was defined as described 
earlier [36].
Statistical Analysis
Distribution of data (continuous variables) was analyzed with 
boxplots, scattergrams and histograms. Although data was 
normally distributed, nonparametric statistical analyses were 
performed due to small group sizes. Association between con-
tinuous variables (age, body weight, hematocrit, hemoglobin 
concentration, tumor volume, and Doppler and oxygen meas-
urements) was assessed by the Spearman rank correlation 
analysis. The relationship between histological classification 
of the tumors and the continuous variables was analyzed by 
use of the Kruskal-Wallis test.
Endpoints after RT were recorded as in Rohrer Bley et 
al. [36]. Progression-free interval (PFI) and overall survival 
were calculated with respect to tumor histology and patient 
characteristics by Kaplan-Meier method, log-rank and Bres-
low-Gehan-Wilcoxon tests, univariate proportional hazards 
and multiple Cox regression analysis (forward/backward step-
wise model). For statistical analysis, StatView® 5.0.1 (SAS 
 Institute Inc., Cary, NC, USA) and SPSS® 10.0 (SPSS Schweiz 
AG, Zurich, Switzerland) were used. Significance was set at a 
p-value of < 0.05.
Results
Animals and Tumors
48 dogs with no life-compromising disease other than the 
known cancer were included. Hematologic parameters were 
in the reference range for all but two dogs, respectively (data 
not shown). Distribution of histology was as follows: sarcomas 
(n = 18), squamous cell carcinomas (n = 17), and malignant 
melanomas (n = 13). Although sarcomas had higher tumor 
volumes (median, 21.2 cm3; range, 2.7–65.4 cm3) than squa-
mous cell carcinomas (median, 8.2 cm3; range, 0.3–57.6 cm3) 
and melanomas (median, 15.7 cm3; range, 0.2–29.9 cm3), the 
median difference was not significant (p = 0.09). Similarly, 
dogs with malignant melanoma tended to be older (median, 
12 years; range, 6–15 years) than animals with sarcoma or 
 squamous cell carcinoma (median, 8.5 years; range, 4–13 years; 
and median, 8 years; range, 1–13 years; p = 0.08). Patient char-
acteristics such as age, body weight, hematocrit, hemoglobin 
concentration and tumor volume did neither significantly cor-
relate with the Doppler nor the oxygen measurements for the 
different tumor histology groups (p = 0.2–0.9).
Contrast-Enhanced Power Doppler Ultrasound of Tumors
Median vascularity (FA) and blood volume (CWFA) differed 
significantly between histology groups (p < 0.0001). Squa-
mous cell carcinomas were highly vascularized and perfused 
(median FA, 36.9%; range, 12.9–69.2%; median CWFA, 26.1; 
range, 6.5–86.1) whereas in malignant melanomas vascularity 
and blood volume were moderate (median FA, 18.1%; range, 
0.2–68.7%; median CWFA, 15.3; range, 0.05–81.4) and in sar-
comas they were low (median FA, 5.0%; range, 0.1–38.8%; 
median CWFA, 3.2; range, 0.02–-19.1). However, there was 
overlap in the ranges between the different types of tumors.
pO2 Measurements
Median pO2 value was lower in sarcoma (median, 8.0 mm-
Hg; range, 0–36.5 mmHg) than in squamous cell carcinoma 
(median, 22.2 mmHg; range, 6.4–56.7 mmHg) and malignant 
melanoma (median, 19.3 mmHg; range, 0–95.4 mmHg; p = 
0.05). Correspondingly, the numbers of pO2 readings ≤ 2.5, 5, 
and 10 mmHg were highest in sarcoma (28.4%, 41.9%, and 
54.4%) in comparison to squamous cell carcinoma (0%, 2.7%, 
and 6.9%) and malignant melanoma (10.4%, 12.1%, and 
17.2%; p = 0.04, 0.05, and 0.1, respectively).
For all tumors, vascularity (FA) and blood volume (CW-
FA) correlated significantly and positively with median pO2 
(r = 0.51 and 0.61; p = 0.001 and < 0.0001) and negatively 
with the percentage of pO2 readings ≤ 2.5, 5, and 10 mmHg 
(r = –0.37 to –0.42; p < 0.01–0.03). However, within the different 
tumor histology groups, values scattered widely and correla-
tion between power Doppler and pO2 values was not significant 
(p = 0.06–0.9).
Treatment Protocols and Response to Treatment
RT was given with curative (n = 26) or palliative (n = 22) in-
tent. The median total doses for curatively treated patients 
with sarcoma were 52.5 Gy (range, 49–56 Gy) and for pallia-
tively treated sarcomas 30 Gy (range, 30–30 Gy). Squamous 
cell carcinomas were treated with 51 Gy (range, 45–51 Gy) 
and malignant melanoma with 24 Gy (range, 18–30 Gy). At 
disease progression, some dogs received additional treatment 
(n = 8). Complete response to treatment was observed in 21 
dogs (44%), partial response in 18 animals (37%), and stable 
disease in nine patients (19%). At the time of analysis, 18 dogs 
were free of progression and seven were still alive. Patients 
were followed up to death or to the close-out date and none 
was lost to follow-up. The median follow-up time for all pa-
tients was 330 days, and for patients still alive (up to close-out 
date) 1,321 days. 28 patients died of tumor-related disease, ten 
for other reasons, and in three cases cause of death could not 
be assessed.
Progression-Free Interval and Overall Survival
PFI and overall survival times are listed in Tables 1a and 1b.
Univariate Models
In the sarcoma and squamous cell carcinoma group, PFI 
was neither significantly associated with age, tumor volume, 
Doppler nor pO2 measurements (Table 2a). However, in 
 squamous cell carcinomas, older dogs lived significantly long-
er and larger tumor volumes were significantly associated with 
longer survival (Table 2b). In palliatively treated melanomas, 
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larger tumor volumes led to a longer PFI and a lower vascular-
ity index was associated with longer survival. For palliatively 
treated sarcomas, no significant associations were found be-
tween age, tumor volume, Doppler and pO2 measurements, 
and PFI or survival (Tables 3a  and 3b).
Multivariate Models
Multiple Cox regression analyses con-
firmed the results of the univariate anal-
ysis; no other significant prognostic fac-
tors were identified for any of the tumor 
groups (data not shown).
Discussion
The goal of this study was to investigate 
whether vascularity and blood volume 
measured via quantified contrast-en-
hanced power Doppler sonography 
would allow a noninvasive estimation of 
tumor tissue oxygenation measured with 
pO2 histography in spontaneous canine 
tumors.
The outcome after RT correlates 
with prior described responses of oral 
tumors in dogs [4–6, 9, 10, 34, 41]. Me-
dian vascularity and blood volume 
differed significantly between histol-
ogy groups: squamous cell carcinomas 
were highly vascularized and perfused, 
whereas in malignant melanomas 
mean vascularity and blood volume 
were moderate and in sarcomas they 
were low. These results confirm re-
cently published data from our group 
[33]. Fibrosarcoma was found to have 
the lowest tissue oxygen pressure with 
median values below the prognosti-
cally relevant described limit of ≤ 10 
mmHg [2, 36], and the high and mod-
erate vascularization and perfusion of 
squamous cell carcinomas and malig-
nant melanoma, respectively, resulted 
in only moderate amounts of hypoxic 
regions. Prognostic significance of 
parameters possibly reflecting tumor 
oxygenation status was only described 
for soft-tissue sarcoma, where increas-
ing microvessel density (MVD) was 
associated with increasing histological 
grade. However, no correlation be-
tween MVD and survival was found 
[27]. Accordingly, none of evaluated 
patient or tumor parameters of this 
study correlated with outcome after 
tumor treatment. This finding is in 
contrast to findings in studies of human 
tumors, where tumor oxygenation has 
Table 1a. Progression-free interval for curatively and palliatively treated patients: while overall 
progression-free interval (PFI) of all patients is significantly different for curatively versus palli-
atively treated patients, no significant differences in PFI are found within the treatment groups. 
CI: confidence interval; NA: not assessed. 
Tabelle 1a. Progressionsfreie Zeit für kurativ und palliativ bestrahlte Patienten: Während sich 
die kurativen und die palliativen Patientengruppen signifikant unterscheiden, ist für die einzel-
nen Gruppen innerhalb eines Behandlungsschemas die progressionsfreie Zeit nicht signifikant 
unterschiedlich. CI: Konfidenzintervall; NA: nicht untersucht. 
 Curatively treated  Palliatively treated  Log-rank test
 patients patients p-value
Histology group Median (days)  Median (days) 
 [95% CI] [95% CI]
All    504 [0;1,386] 142 [32;362] 0.0005
Squamous cell carcinoma    609 [0;1,261] NA 
Fibrosarcoma 1,134 [0;2,232] 139 [0;285] 
Malignant melanoma NA 112 [10;214] 
Table 1b. Overall survival for curatively and palliatively treated patients: while overall survival 
of all patients is significantly different for curatively versus palliatively treated patients, no si-
gnificant differences in survival are found within the treatment groups. CI: confidence interval; 
NA: not assessed. 
Tabelle 1b. Überlebenszeit für kurativ und palliativ bestrahlte Patienten: Während sich die ku-
rativen und die palliativen Patientengruppen signifikant unterscheiden, ist für die einzelnen 
Gruppen innerhalb eines Behandlungsschemas die Überlebenszeit nicht signifikant unter-
schiedlich. CI: Konfidenzintervall; NA: nicht untersucht. 
 Curatively treated  Palliatively treated  Log-rank test
 patients patients p-value
Histology group Median (days)  Median (days) 
 [95% CI] [95% CI]
All 711 [0;1,481] 137 [77;197] 0.0008
Squamous cell carcinoma 733 [0;17,559] NA 
Fibrosarcoma 437 [222;649] 159 [61;257] 
Malignant melanoma NA 142 [0;290] 
Table 2a. Univariate proportional hazard Cox regression results for influences on progression-
free interval: curatively treated patients. CWFA: color-weighted fractional area; FA: fractional 
area; SE: standard error; TV: tumor volume. 
Tabelle 2a. Resultate der univariaten proportionalen Risikoregressionsanalyse für Einflüsse auf 
die progressionsfreie Zeit: kurativ behandelte Patienten. CWFA: Blutvolumen; FA: vaskularisier-
te Fläche; SE: Standardfehler; TV: Tumorvolumen. 
 Squamous cell carcinoma Sarcoma
Variable Coefficient (SE) p-value Coefficient (SE) p-value
Age 0.041 (0.123) 0.736 –0.505 (0.377) 0.180
lnTV 0.420 (0.331) 0.205 –0.133 (0.517) 0.796
FA 0.041 (0.029) 0.150   0.187 (0.098) 0.057
CWFA 0.019 (0.016) 0.235   0.174 (0.096) 0.069
Median pO2 0.013 (0.030) 0.656   0.051 (0.065) 0.433
% pO2 ≤ 10 mmHg 0.019 (0.021) 0.365 –0.023 (0.027) 0.399
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been found to be of independent significance in a variety of 
tumors [7, 8, 12, 18, 19, 21, 29–31, 37].
The parallel use of several different methods including 
endogenous hypoxia markers was found to be desirable to 
describe a profile of tumor oxygenation to be used for di-
agnostic and prognostic purposes [11, 22, 28, 35]. Various 
techniques leading to partially overlapping data will provide 
validation of the measurements and result in a more accurate 
tumor oxygenation profile [13, 23, 28]. The analyzed Dop-
pler parameters correlated significantly with pO2 measure-
ments for all tumors, but not within the tumor histological 
groups. This correlation for all tumors may be explained 
statistically by the fact that both meas-
urements differed within the various 
groups and values scattered widely. 
In humans, moderate correlations be-
tween the two technologies were found 
in metastases of head-and-neck cancer 
[17, 39]. In contrast to these studies, we 
used contrast-enhanced power Dop-
pler ultrasound which has been shown 
to be more sensitive than contrast-
enhanced color Doppler for detect-
ing low velocities and depicting small 
vessels [26, 42]. It was hypothesized by 
our group that using the more sensitive 
technology, results would correlate to 
pO2 measurements to an even higher 
degree than described in the literature 
[15, 16]. However, measurement of tu-
mor vascularity and blood volume with 
contrast-enhanced power Doppler 
ultrasound and pO2 histography obvi-
ously yielded different biological infor-
mation in the present study. Neverthe-
less, according to clinical experience 
blood flow and tumor oxygenation are 
important factors which modulate the 
sensitivity of cancer cells. It has been 
suggested that measurements of global 
blood flow and vascularity will be use-
ful in the early assessment of therapeu-
tic response [13, 45].
One important reason for the lack 
of correlation between the two tech-
nologies may have been the fact that 
vascularity and blood volume may not 
completely reflect tumor oxygenation 
status. Approaches used to measure 
tumor perfusion do not necessarily 
provide the information on events oc-
curring at the microscopic level [13]. 
Speed and direction of blood flow in 
the tumor are unstable; functionality 
of tumor vessels may be impaired in 
certain tumors and is likely to lead to 
the occurrence of fluctuating hypoxia 
within the tumor microenvironment.
Moreover, results of the present 
study may be limited because sample 
Table 2b. Univariate proportional hazard Cox regression results for influences on survival: cura-
tively treated patients. CWFA: color-weighted fractional area; FA: fractional area; SE: standard 
error; TV: tumor volume. 
Tabelle 2b. Resultate der univariaten proportionalen Risikoregressionsanalyse für Einflüsse auf 
die Überlebenszeit: kurativ behandelte Patienten. CWFA: Blutvolumen; FA: vaskularisierte Flä-
che; SE: Standardfehler; TV: Tumorvolumen. 
 Squamous cell carcinoma  Sarcoma
Variable Coefficient (SE) P-value Coefficient (SE) p-value
Age   0.328 (0.125) 0.009   0.095 (0.259) 0.713
lnTV   0.610 (0.300) 0.042 –0.528 (0.418) 0.207
FA –0.014 (0.024) 0.542 –0.008 (0.056) 0.882
CWFA –0.012 (0.017) 0.490 –0.012 (0.063) 0.843
Median pO2 –0.006 (0.023) 0.786 –0.020 (0.030) 0.510
% pO2 ≤ 10 mmHg –0.001 (0.017) 0.940   0.002 (0.010) 0.869
Table 3a. Univariate proportional hazard Cox regression results for influences on progres-
sion-free interval: palliatively treated patients. CWFA: color-weighted fractional area; FA: frac-
tional area; SE: standard error; TV: tumor volume. 
Tabelle 3a. Resultate der univariaten proportionalen Risikoregressionsanalyse für Einflüsse auf 
die progressionsfreie Zeit: palliativ behandelte Patienten. CWFA: Blutvolumen; FA: vaskularisier-
te Fläche; SE: Standardfehler; TV: Tumorvolumen. 
 Melanoma  Sarcoma 
Variable Coefficient (SE) P-value Coefficient (SE) p-value
Age –0.027 (0.109) 0.800 –0.448 (0.284) 0.115
lnTV   1.022 (0.490) 0.037   0.389 (0.552) 0.482
FA –0.029 (0.022) 0.193   0.028 (0.043) 0.510
CWFA –0.016 (0.018) 0.398   0.025 (0.063) 0.693
Median pO2 –0.012 (0.009) 0.199 –0.015 (0.032) 0.638
% pO2 ≤ 10 mmHg   0.008 (0.010) 0.394   0.002 (0.011) 0.878
Table 3b. Univariate proportional hazard Cox regression results for influences on survival: palli-
atively treated patients. CWFA: color-weighted fractional area; FA: fractional area; SE: standard 
error; TV: tumor volume. 
Tabelle 3b. Resultate der univariaten proportionalen Risikoregressionsanalyse für Einflüsse auf 
die Überlebenszeit: palliativ behandelte Patienten. CWFA: Blutvolumen; FA: vaskularisierte Flä-
che; SE: Standardfehler; TV: Tumorvolumen. 
 Melanoma  Sarcoma
Variable Coefficient (SE) p-value Coefficient (SE) p-value
Age   0.091 (0.106) 0.392 –0.137 (0.218) 0.530
lnTV   0.543 (0.341) 0.111   0.809 (0.596) 0.175
FA –0.066 (0.029) 0.023 –0.013 (0.035) 0.711
CWFA –0.046 (0.025) 0.068 –0.025 (0.058) 0.659
Median pO2 –0.003 (0.009) 0.720 –0.020 (0.030) 0.510
% pO2 ≤ 10 mmHg –0.003 (0.007) 0.678   0.002 (0.010) 0.869
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volumes of pO2 histography and contrast-enhanced power 
Doppler ultrasound differed. The authors were aware of this 
problem when planning the study. Therefore, pO2 measure-
ments were made under ultrasound guidance in the same 
image plane of the contrast-enhanced power Doppler ul-
trasound examination, and three needle tracks (at least 50 
measurements/track) in different locations were performed. 
It would have been difficult to obtain more tracks from one 
tumor, since many tumors were small. However, multiple 
tracks may still have not reflected the complete ultrasound 
image or the heterogeneous character of tumors.
In various human tumors, significant associations be-
tween high vascularity determined via color Doppler ul-
trasonography with or without contrast enhancement, and 
tumor aggressiveness, metastatic rate and decreased patient 
survival have been shown [24, 25, 32, 38]. However, in the 
patient population with oral tumors examined in the present 
study, none of the parameters were of prognostic value.
Conclusion
Although vascularity and blood volume correlated signifi-
cantly with the descriptors of tissue oxygen tension, signifi-
cance was lost by investigating the results for the different 
tumor histology and treatment groups. Neither univariate 
nor multivariate models were able to show that any of the 
methods could reliably predict outcome in these patients.
The authors feel that the results will have an impact on 
further research in tumor oxygenation and perfusion com-
paring invasive to noninvasive methods, even if the initially 
proposed hypothesis of correlation and prognostic signifi-
cance for these tumor and patient populations did not prove 
true. 
References
1. Achermann R, Ohlerth S, Fidel J, et al. Ultrasound guided, pre-radiation 
oxygen measurements using polarographic oxygen needle electrodes in 
spontaneous canine soft tissue sarcomas. In Vivo 2002;16:431–7.
2. Achermann RE, Ohlerth SM, Rohrer Bley C, et al. Oxygenation of sponta-
neous canine tumors during fractionated radiation therapy. Strahlenther 
Onkol 2004;180:297–305.
3. Auer F, Röper B, Scheich D, et al. Technical improvement of pO2 measure-
ments in breast cancer. Investigation of the feasibility in patients and in 
vitro validation of the method. Strahlenther Onkol 2007;183:265–70.
4. Bateman KE, Catton PA, Pennock PW, et al. 0-7-21 radiation therapy for the 
treatment of canine oral melanoma. J Vet Intern Med 1994;8:267–72.
5. Bergman PJ. Canine oral melanoma. Clin Tech Small Anim Pract 2007;22:
55–60.
6. Blackwood L, Dobson JM. Radiotherapy of oral malignant melanomas in 
dogs. J Am Vet Med Assoc 1996;209:98–102.
7. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the 
likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 
1996;56:941–3.
8. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the 
prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 
1997;38:285–9.
9. Burk RL. Radiation therapy in the treatment of oral neoplasia. Vet Clin 
North Am Small Anim Pract 1996;26:155–63.
10. Ciekot PA, Powers BE, Withrow SJ, et al. Histologically low-grade, yet bio-
logically high-grade, fibrosarcomas of the mandible and maxilla in dogs: 25 
cases (1982–1991). J Am Vet Med Assoc 1994;204:610–5.
11. Dellas K, Bache M, Pigorsch SU, et al. Prognostic impact of HIF-1α expres-
sion in patients with definitive radiotherapy for cervical cancer. Strahlen-
ther Onkol 2008;184:169–74.
12. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in hu-
mans. Cancer Lett 2003;195:1–16.
13. Feldmann HJ, Molls M, Vaupel P. Blood flow and oxygenation status of hu-
man tumors. Clinical investigations. Strahlenther Onkol 1999;175:1–9.
14. Fleischer AC, Wojcicki WE, Donnelly EF, et al. Quantified color Doppler 
sonography of tumor vascularity in an animal model. J Ultrasound Med 
1999;18:547–51.
15. Gagel B, DiMartino E, Schramm O, et al. Contrast-enhanced color duplex 
sonography (CDS): an alternative for the evaluation of therapy-relevant 
tumor oxygenation? Strahlenther Onkol 2006;182:604–9.
16. Gagel B, Piroth M, Pinkawa M, et al. pO polarography, contrast enhanced 
color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluoro-
deoxyglucose positron emission tomography: validated methods for the 
evaluation of therapy-relevant tumor oxygenation or only bricks in the 
puzzle of tumor hypoxia? BMC Cancer 2007;7:113.
17. Gagel B, Reinartz P, Dimartino E, et al. pO2 polarography versus positron 
emission tomography ([18F] fluoromisonidazole, [18F]-2-fluoro-2’-deoxyglu-
cose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther 
Onkol 2004;180:616–22.
18. Harrison LB, Chadha M, Hill RJ, et al. Impact of tumor hypoxia and anemia 
on radiation therapy outcomes. Oncologist 2002;7:492–508.
19. Höckel M, Knoop C, Schlenger K, et al. Intratumoral pO2 predicts survival in 
advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45–50.
20. Höckel M, Schlenger K, Knoop C, et al. Oxygenation of carcinomas of the 
uterine cervix: evaluation by computerized O2 tension measurements. Can-
cer Res 1991;51:6098–102.
21. Höckel M, Schlenger K, Mitze M, et al. Hypoxia and radiation response in 
human tumors. Semin Radiat Oncol 1996;6:3–9.
22. Kappler M, Taubert H, Holzhausen HJ, et al. Immunohistochemical detec-
tion of HIF-1α and CAIX in advanced head-and-neck cancer. Prognostic role 
and correlation with tumor markers and tumor oxygenation parameters. 
Strahlenther Onkol 2008;184:393–9. 
23. Kotas M, Schmitt P, Jakob PM, et al. Monitoring of tumor oxygenation 
changes in head-and-neck carcinoma patients breathing a hyperoxic hyper-
capnic gas mixture with a noninvasive MRI technique. Strahlenther Onkol 
2009;185:19–26.
24. Lassau N, Lamuraglia M, Vanel D, et al. Doppler US with perfusion soft-
ware and contrast medium injection in the early evaluation of isolated 
limb perfusion of limb sarcomas: prospective study of 49 cases. Ann Oncol 
2005;16:1054–60.
25. Lassau N, Mercier S, Koscielny S, et al. Prognostic value of high-frequency 
sonography and color Doppler sonography for the preoperative assessment 
of melanomas. AJR Am J Roentgenol 1999;172:457–61.
26. Lencioni R, Mascalchi M, Caramella D, et al. Small hepatocellular carcinoma: 
differentiation from adenomatous hyperplasia with color Doppler US and 
dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 1996;21:41–8.
27. Luong RH, Baer KE, Craft DM, et al. Prognostic significance of intratumoral 
microvessel density in canine soft-tissue sarcomas. Vet Pathol 2006;43:
622–31.
28. Menon C, Polin GM, Prabakaran I, et al. An integrated approach to measur-
ing tumor oxygen status using human melanoma xenografts as a model. 
Cancer Res 2003;63:7232–40.
29. Nordsmark M, Hoyer M, Keller J, et al. The relationship between tumor oxy-
genation and cell proliferation in human soft tissue sarcomas. Int J Radiat 
Oncol Biol Phys 1996;35:701–8.
30. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation 
status and loco-regional control in advanced head and neck squamous cell 
carcinoma treated by radiation therapy. Radiother Oncol 2000;57:39–43.
31. Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin 
and prognostic for loco-regional tumor control after primary radiotherapy 
in advanced head and neck cancer. Acta Oncol 2004;43:396–403.
761Strahlenther Onkol 2009 · No. 11
Rohrer Bley C, et al. Correlation of Tissue pO2 and Power Doppler US
32. Ogura O, Takebayashi Y, Sameshima T, et al. Preoperative assessment of 
vascularity by color Doppler ultrasonography in human rectal carcinoma. 
Dis Colon Rectum 2001;44:538–46, discussion 546–8.  
33. Ohlerth S, Wergin M, Rohrer Bley C, et al. Correlation of quantified con-
trast-enhanced power Doppler ultrasonography with immunofluorescent 
analysis of microvessel density in spontaneous canine tumours. Vet J 2008; 
doi: 10.1016/j.tvjl.2008.08.026.
34. Poirier VJ, Bley CR, Roos M, et al. Efficacy of radiation therapy for the 
treatment of macroscopic canine oral soft tissue sarcoma. In Vivo 2006;20:
415–9.
35. Rades D, Golke H, Schild SE, et al. Impact of VEGF and VEGF receptor 1 
(FLT1) expression on the prognosis of stage III esophageal cancer patients 
after radiochemotherapy. Strahlenther Onkol 2008;184:416–20.
36. Rohrer Bley C, Ohlerth S, Roos M, et al. Influence of pretreatment po-
larographically measured oxygenation levels in spontaneous canine tumors 
treated with radiation therapy. Strahlenther Onkol 2006;182:518–24.
37. Rudat V, Stadler P, Becker A, et al. Predictive value of the tumor oxygena-
tion by means of pO2 histography in patients with advanced head and neck 
cancer. Strahlenther Onkol 2001;177:462–8.
38. Rudat V, Vanselow B, Wollensack P, et al. Repeatability and prognostic im-
pact of the pretreatment pO2 histography in patients with advanced head 
and neck cancer. Radiother Oncol 2000;57:31–7.
39. Scholbach T, Scholbach J, Krombach GA, et al. New method of dynamic 
color Doppler signal quantification in metastatic lymph nodes compared 
to direct polarographic measurements of tissue oxygenation. Int J Cancer 
2005;114:957–62.
40. Steel GG. The growth rate of tumours. In: Steel GG, ed. Basic clinical radio-
biology. New York: Arnold, 2002:8–22.
41. Theon AP, Rodriguez C, Madewell BR. Analysis of prognostic factors and 
patterns of failure in dogs with malignant oral tumors treated with mega-
voltage irradiation. J Am Vet Med Assoc 1997;210:778–84.
42. Tschammler A, Beer M, Hahn D. Differential diagnosis of lymphadenopa-
thy: power Doppler vs color Doppler sonography. Eur Radiol 2002;12:
1794–9.
43. Vaupel P, Hockel M, Mayer A. Detection and characterization of tumor hy-
poxia using pO2 histography. Antioxid Redox Signal 2007;9:1221–35.
44. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, 
and metabolic microenvironment of human tumors: a review. Cancer Res 
1989;49:6449–65.
45. Vaupel P, Kelleher DK, Thews O. Modulation of tumor oxygenation. Int J 
Radiat Oncol Biol Phys 1998;42:843–8.
Address for Correspondence
Carla Rohrer Bley
Section of Radiooncology
Vetsuisse Faculty
University of Zurich
Winterthurerstraße 260
8057 Zürich
Switzerland
Phone (+41/44) 635-8487, Fax -8940
e-mail: crohrer@vetclinics.uzh.ch
762 Strahlenther Onkol 2009 · No. 11
